Losartan HCTZ tablets recalled for manufacturing impurity levels above acceptable limits
RemedyRepack Inc. is recalling Losartan HCTZ 100/12.5 mg tablets due to elevated AZIDO impurity levels exceeding acceptable manufacturing standards. The recall affects bottles distributed to Florida, South Carolina, and Virginia.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is classified as FDA Class II, which indicates a serious quality issue. However, no illnesses, injuries, or deaths have been reported in connection with this recall. The manufacturing deviation resulting in elevated AZIDO impurity levels represents a potential risk of harm, warranting a High severity score per the rubric for risk-of-harm products where injury has not yet been reported.
Plain-English summary
RemedyRepack Inc. is recalling Losartan HCTZ 100/12.5 mg tablets packaged in 90-count bottles (NDC 70518-2564-00) due to a manufacturing quality issue.
The recall was initiated because testing identified AZIDO impurity levels above acceptable limits in the affected product. This represents a deviation from current good manufacturing practices (CGMP).
The recalled product was distributed to patients in Florida, South Carolina, and Virginia. The affected lot numbers are B1364261-092721 (expiration 09/30/2022), B1377667-100521 (expiration 10/31/2022), B1412576-102621 (expiration 10/31/2022), and B1436925-111321 (expiration 11/30/2022).
Patients with this product should contact their pharmacy or healthcare provider for guidance regarding this recall.
The recalled product
- Product
- Losartan HCTZ 100/12.5 mg, 90 count bottles NDC# 70518-2564-00 Repackaged NDC Original NDC # 68180-0216-09
- Manufacturer
- RemedyRepack Inc.
- Category
- Drug
- Hazard
- manufacturing-deviation
- azido-impurity
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot # B1364261-092721
- exp. date 09/30/2022 B1377667-100521
- exp. date 10/31/2022 B1412576-102621
- exp. date 10/31/2022 B1436925-111321
- exp. date 11/30/2022
Distribution
Distributed in 3 states:
- FL
- SC
- VA
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27